|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
CA2333554A1
(en)
|
1998-06-17 |
1999-12-23 |
Chu-Baio Xue |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
PL351470A1
(en)
|
1999-04-28 |
2003-04-22 |
Aventis Pharma Gmbh |
Tri-aryl acid derivatives as ppar receptor ligands
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
WO2001014882A1
(fr)
|
1999-08-23 |
2001-03-01 |
Bml, Inc. |
Identification des proprietes d'une substance pour les recepteurs de prostaglandine d
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
AU2002302248B2
(en)
|
2001-05-23 |
2008-03-06 |
Merck Frosst Canada Ltd. |
Dihydropyrrolo[1,2-A]indole and tetrahydropyrido[1,2-A]-indole derivatives as prostaglandin D2 receptor antagonists
|
|
CA2452391A1
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
BR0212512A
(pt)
*
|
2001-09-14 |
2004-10-26 |
Tularik Inc |
Composto, composição farmacêutica e métodos para tratar um distúrbio, condição ou doença, elevar os nìveis do colesterol hdl, reduzir os nìveis de triglicerìdeo, tratar diabete, diminuir a resistência à insulina ou diminuir a pressão arterial e modular a ppardelta
|
|
WO2004039807A1
(en)
|
2002-10-30 |
2004-05-13 |
Merck Frosst Canada & Co. |
Pyridopyrrolizine and pyridoindolizine derivatives
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
PL377314A1
(pl)
*
|
2002-12-20 |
2006-01-23 |
Amgen Inc. |
Modulatory astmy i zapaleń na tle alergicznym
|
|
PT1471057E
(pt)
|
2003-04-25 |
2006-05-31 |
Actimis Pharmaceuticals Inc |
Derivados de acido pirimidinilacetico uteis para o tratamento de doencas mediadas por crth2
|
|
US20070232681A1
(en)
|
2003-10-14 |
2007-10-04 |
Oxagen Limited |
Compounds Having Crth2 Antagonist Activity
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
WO2005051373A1
(ja)
|
2003-11-26 |
2005-06-09 |
Takeda Pharmaceutical Company Limited |
受容体機能調節剤
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
CA2562082C
(en)
|
2004-04-13 |
2013-06-25 |
Merck & Co., Inc. |
Cetp inhibitors for the treatment and prevention of atherosclerosis
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
ATE413167T1
(de)
|
2004-08-17 |
2008-11-15 |
Galderma Res & Dev |
Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
|
|
WO2006034419A2
(en)
|
2004-09-21 |
2006-03-30 |
Athersys, Inc. |
Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
|
|
EP1814865A4
(en)
|
2004-09-21 |
2009-09-02 |
Wyeth Corp |
BENZIMIDAZOL ACETIC ACIDS WITH CRTH2 RECEPTOR ANTAGONISM AND ITS APPLICATIONS
|
|
US20070299122A1
(en)
|
2004-11-08 |
2007-12-27 |
Tobert Jonathan A |
Method of Treating Pathological Blushing
|
|
JP2008520645A
(ja)
|
2004-11-23 |
2008-06-19 |
ファイザー・プロダクツ・インク |
ジベンジルアミン化合物および誘導体
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
EP2407459A1
(en)
|
2005-09-27 |
2012-01-18 |
Shionogi & Co., Ltd. |
Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
EP1937632A1
(en)
|
2005-10-06 |
2008-07-02 |
Astra Zeneca AB |
Novel compounds
|
|
TW200732296A
(en)
*
|
2005-12-15 |
2007-09-01 |
Astrazeneca Ab |
Novel compounds
|
|
LT1976828T
(lt)
|
2005-12-29 |
2017-04-25 |
Celtaxsys, Inc. |
Diamino dariniai, kaip leukotrieno a4 hidrolazės inhibitoriai
|
|
WO2007146838A2
(en)
*
|
2006-06-09 |
2007-12-21 |
Icos Corporation |
Substituted phenyl acetic acids as dp-2 antagonists
|
|
AU2007286829B2
(en)
*
|
2006-08-21 |
2013-05-02 |
Array Biopharma, Inc. |
4-substituted phenoxyphenylacetic acid derivatives
|
|
TWI519508B
(zh)
|
2007-06-12 |
2016-02-01 |
Achaogen Inc |
抗菌劑
|
|
CA2691662A1
(en)
|
2007-07-02 |
2009-01-08 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as ccr2 receptor antagonists
|
|
RU2010116821A
(ru)
|
2007-10-01 |
2011-11-10 |
Ф.Хоффманн-Ля Аг (Ch) |
N-гетероциклические биарильные карбоксамиды в качестве антагонистов рецептора ccr
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
CA2712017C
(en)
|
2008-01-18 |
2016-08-09 |
Oxagen Limited |
Compounds having crth2 antagonist activity
|
|
BRPI0907364A2
(pt)
|
2008-02-01 |
2015-07-14 |
Amira Pharmaceuticals Inc |
Antagonistas aminoalquilbifenil n,n-disubstituídos de receptores d2 de prostaglandina
|
|
WO2009099901A1
(en)
|
2008-02-01 |
2009-08-13 |
Amira Pharmaceuticals, Inc. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
WO2009102893A2
(en)
|
2008-02-14 |
2009-08-20 |
Amira Pharmaceuticals, Inc. |
CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
|
|
US8426449B2
(en)
*
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
US8071807B2
(en)
|
2008-07-03 |
2011-12-06 |
Panmira Pharmaceuticals, Llc |
Antagonists of prostaglandin D2 receptors
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
WO2010042652A2
(en)
|
2008-10-08 |
2010-04-15 |
Amira Pharmaceuticals, Inc. |
Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
EP2461809A4
(en)
*
|
2009-07-31 |
2013-06-19 |
Panmira Pharmaceuticals Llc |
OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF DP2 RECEPTOR ANTAGONSITES
|
|
KR20120046762A
(ko)
|
2009-07-31 |
2012-05-10 |
판미라 파마슈티칼스, 엘엘씨 |
Ｄｐ2 수용체 길항제의 피부 제형
|